BioCentury
ARTICLE | Clinical News

D-Ivacaftor: Phase I started

November 23, 2015 8:00 AM UTC

Concert began a double-blind, Australian Phase I trial of oral CTP-656 in 38 healthy volunteers. The first part will compare a single 150 mg dose of CTP-656 vs. a single dose of 150 mg oral Kalydeco ...